Innohep Death Risk for Elderly Leads to New Warning
Celgene Corp. sent a letter last week to healthcare providers warning that their blood thinner Innohep may increase the risk of death in elderly patients with kidney problems, recommending that…
Celgene Corp. sent a letter last week to healthcare providers warning that their blood thinner Innohep may increase the risk of death in elderly patients with kidney problems, recommending that…
The FDA has issued an early communication about an on-going safety review into potential side effects of Innohep, a low-molecular weight heparin. The agency has asked the drug maker to…
Side effects of Innohep, a low molecular weight heparin, have been linked to an increased risk of death when used to treat deep vein thrombosis (DVT) or pulmonary embolism among…